The annual Sunbright Super Festival has come to a successful conclusion.

The annual Sunbright Super Festival has come to a successful conclusion. New & old users of Sunbright Company have received greatest discounts and support, and the products of Sunbright Company have become more and more familiar to more and more people. The 5.21 Purchasing Festival is a very important event for Sunbright Company, and the discount to customers in this festival is unprecedentedly maximized.

The Sunbright Purchasing Festival has successfully completed the task, among which the top three sales are:

First one, series of Color Doppler: Sunbright’s color Doppler ultrasound Sun-906A, Sun-906B, Sun-906C, Sun-908A, Sun-908B, Sun-908C, Sun-901A, Sun-901B, Sun-901C, their images are of superior quality, and their prices are superior competitive. With the help of professional doctors and engineers, we have trained hundreds of dealers, and many dealers have become more and more professional because of Sunbright’s training, thus achieving good sales performance in their markets. During the Sunbright Super Festival, Sunbright sold 136 units of color Doppler.

Secondly, series of blark & white ultrasound: especially Sun-800D, which have been well received by a large number of customersin the world. This machine has European and American style appearance, excellent image quality, computer platform, and humanized design. This is a product exclusively produced and sold by Sunbright company. There may be similar ones on the market, but only the appearance is similar, and the performance cannot reach the excellent performance of 800D.

Last but not least, serises of patient monitor of sunbright: Sunbright’s monitors have undergone continuous product upgrades. Currently, anesthesia gas module, anesthesia depth module, and PVI index measurement can be selected. Among them, PVI index measurement is a major technological breakthrough of ours.

The Pleth Variability Index (PVI) is a breakthrough measurement technology that helps clinicians non-invasively and continuously assess a patient’s infusion status.

Infusion management is important to improve patient condition. Traditional methods to guide infusion management often fail to predict infusion reactions. New methods can accurately predict response but are invasive or expensive. PVI has been confirmed to help clinicians predict infusion  response in patients receiving mechanical oxygen during surgery and intensive care and under general anesthesia.PVI has been confirmed to help clinicians improve infusion management and is compatible with standard care compared to lower lactate levels.

“PVI has demonstrated high accuracy in distinguishing in distinguishing infusion responders from non-responders, which is the only opportunity to improve cardiac function and organ perfusion levels through better management of patients’ infusion volumes.””Maxime Cannesson, MD

Associate Professor of Anesthesiology,

Department of Anesthesiology and Perioperative Nursing, UC Irvine

PVI has been probed to help clinicians predict infusion response under general anesthesia in patients receiving mechanical oxygen, as defined by a marked increase in cardiac output following infusion management.

If PVI before capacity expansion is >14%,100-Specificity(%),the patient will be predicted to have an infusion reaction (81% sensitivity).

If PVI before capacity expansion is <14%, the patient will be predicted that will not have an infusion reaction (100% specificity).